Found 9 matching trials
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
PHASE1Patients have a type of cancer called sarcoma. Because there is no standard...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
PHASE1This is a Phase I study to evaluate the safety profile of a type of immune ...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
PHASE1This is an open-label, non-randomized, multicenter Phase 1/2 trial evaluati...
Location
District One Hospital
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PHASE1This study is for patients that have a type of brain cancer called glioblas...
Location
Houston Methodist Hospital
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
PHASE1Phase I/II study of adoptive immunotherapy for advanced MUC1\* positive bre...
Location
City of Hope Medical Center
T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors
PHASE1This study is for patients that have brain cancer. The body has different w...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
PHASE1This is a Phase 1 study of central nervous system (CNS) locoregional adopti...
Status
Active Not Recruiting
Location
Seattle Children's Hospital
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
PHASE1The purpose of this study is to find the biggest dose of HTR2 T cells that ...
Location
Houston Methodist Hospital
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
PHASE1A pilot study to determine the safety and efficacy of chimeric antigen rece...